-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Initiates Coverage On Tandem Diabetes Care with Neutral Rating, Announces Price Target of $20

Benzinga·04/10/2025 11:20:09
Listen to the news
Mizuho analyst Anthony Petrone initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral rating and announces Price Target of $20.